Early Improvements With Atogepant for the Preventive Treatment of Migraine | Neurology
Background and ObjectivesThree phase 3 trials demonstrated the efficacy and safety of atogepant in episodic migraine (EM) and chronic migraine (CM) across 12-week treatment periods. This analysis evaluates improvements in efficacy and functional outcomes …